Mechanisms and prospects of ischemic tolerance induced by cerebral preconditioning.
In the brain, brief episodes of ischemia induce tolerance against a subsequent severe episode of ischemia. This phenomenon of endogenous neuroprotection is known as preconditioning-induced ischemic tolerance. The purpose of this review is to summarize the current state of knowledge about mechanisms and potential applications of cerebral preconditioning and ischemic tolerance. Articles related to the terms ischemic preconditioning and ischemic tolerance were systematically searched via MEDLINE/PubMed, and articles published in English related to the nervous system were selected and analyzed. The past two decades have provided interesting insights into the molecular mechanisms of this neuroprotective phenomenon. Although both rapid and delayed types of tolerance have been documented in experimental settings, the delayed type has been found to be more prominent in the case of neuronal ischemic tolerance. Many intracellular signaling pathways have been implicated regarding ischemic preconditioning. Most of these are associated with membrane receptors, kinase cascades, and transcription factors. Moreover, ischemic tolerance can be induced by exposing animals or cells to diverse types of endogenous and exogenous stimuli that are not necessarily hypoxic or ischemic in nature. These cross-tolerances raise the hope that, in the future, it will be possible to pharmacologically activate or mimic ischemic tolerance in the human brain. Another promising approach is remote preconditioning in which preconditioning of one organ or system leads to the protection of a different (remote) organ that is difficult to target, such as the brain. The preconditioning strategy and related interventions can confer neuroprotection in experimental ischemia, and, thus, have promise for practical applications in cases of vascular neurosurgery and endo-vascular therapy.
Kyung Hee University College of Nursing Science, Seoul, Korea.
Mohammad Iqbal Hossain
MI
Bhuiyan
Youn Jung
YJ
Kim
Int Anesthesiol Clin. 1964 Feb;2:251-69
14125012
Cardiovasc Res. 1984 May;18(5):264-9
6733731
Ann Neurol. 1993 May;33(5):457-64
7684582
Neurosci Behav Physiol. 2005 Jul;35(6):567-72
16342612
Brain Res. 1999 May 8;827(1-2):143-51
10320703
J Neurosci. 1999 Mar 1;19(5):1657-62
10024352
Trends Neurosci. 2003 May;26(5):248-54
12744841
Annu Rev Physiol. 1999;61:243-82
10099689
J Cereb Blood Flow Metab. 2002 Nov;22(11):1283-96
12439285
J Neurosci. 2001 Jul 1;21(13):4668-77
11425894
Oncogene. 2001 Apr 30;20(19):2424-37
11402338
Am J Physiol. 1999 May;276(5):C1171-83
10329967
Brain Res. 2000 Jul 28;872(1-2):282-93
10924710
Neurosci Lett. 2005 Apr 4;377(3):206-11
15755527
Brain Res. 1999 Jul 31;836(1-2):62-9
10415405
J Cereb Blood Flow Metab. 1999 Jul;19(7):757-61
10413030
J Vet Med Sci. 2004 May;66(5):521-7
15187362
Circulation. 1986 Nov;74(5):1124-36
3769170
Neuroreport. 2002 Aug 7;13(11):1431-5
12167768
Acta Neurochir Suppl. 1999;73:57-61
10494342
Brain Res. 2002 Oct 18;952(2):153-8
12376175
Ann Neurol. 2003 Dec;54(6):811-9
14681891
Stroke. 2004 Mar;35(3):616-21
14963288
Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):436-41
10618436
Brain Res. 1986 May 28;374(2):244-8
3719335
Brain Res Rev. 2007 Apr;54(1):34-66
17222914
Arch Surg. 2005 Apr;140(4):405-9; discussion 410
15837893
J Biol Chem. 2000 Apr 21;275(16):11981-6
10766828
Neuroreport. 1999 Apr 6;10(5):931-5
10321462
Nat Rev Neurosci. 2006 Jun;7(6):437-48
16715053
Biol Pharm Bull. 2010;33(1):11-7
20045928
Cardiovasc Res. 2008 Aug 1;79(3):377-86
18456674
FEBS Lett. 1997 Sep 1;414(1):117-21
9305743
BJU Int. 1999 Sep;84(4):489-94
10468768
J Cereb Blood Flow Metab. 2007 Jun;27(6):1108-28
17047683
Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2362-7
11842229
J Cereb Blood Flow Metab. 2006 Sep;26(9):1141-7
16395277
J Cereb Blood Flow Metab. 2002 Feb;22(2):142-52
11823712
Life Sci. 1996;59(12):979-85
8809211
Eur J Cardiothorac Surg. 2007 Aug;32(2):319-25
17574858
J Cereb Blood Flow Metab. 1998 May;18(5):472-5
9591839
Neurology. 1989 Oct;39(10):1396-8
2797463
J Biol Chem. 1999 Aug 6;274(32):22569-80
10428835
Neurobiol Dis. 2002 Apr;9(3):294-304
11950275
J Cereb Blood Flow Metab. 1999 Oct;19(10):1126-35
10532637
Stroke. 1998 Sep;29(9):1937-50; discussion 1950-1
9731622
Neurosci Lett. 2006 Aug 14;404(1-2):170-5
16781056
J Cereb Blood Flow Metab. 1999 Mar;19(3):331-40
10078885
J Lab Clin Med. 1996 Sep;128(3):251-8
8783632
Brain Res. 1991 Oct 11;561(2):203-11
1802339
Nat Biotechnol. 1998 Sep;16(9):833-8
9743115
J Neurochem. 2001 Apr;77(2):353-71
11299298
J Vasc Interv Radiol. 2004 Jan;15(1 Pt 2):S3-12
15101511
Anesth Analg. 2007 Sep;105(3):629-40
17717216
Acta Physiol Hung. 2005;92(1):67-92
16003947
Neuroscience. 2008 Feb 19;151(4):1099-103
18201834
Stroke. 2002 Apr;33(4):1093-100
11935066
Int J Biochem Cell Biol. 2008;40(4):651-62
18054269
Neurology. 2000 Jun 13;54(11):2089-94
10851368
Free Radic Biol Med. 2001 Sep 1;31(5):563-73
11522441
Anesthesiology. 2007 Feb;106(2):262-8
17264719
Cell Calcium. 2003 Oct-Nov;34(4-5):325-37
12909079
Neurochem Res. 2004 Apr;29(4):797-804
15098944
Lancet Neurol. 2009 Apr;8(4):398-412
19296922
Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12866-9
10536014
Circulation. 1997 Sep 2;96(5):1641-6
9315559
J Biol Chem. 2005 Apr 22;280(16):16208-18
15687501
Proc Natl Acad Sci U S A. 1998 May 12;95(10):5773-8
9576960
Life Sci. 2007 Mar 6;80(13):1157-75
17258776
Acta Neuropathol. 2003 Mar;105(3):197-202
12557004
Circulation. 2007 Sep 11;116(11 Suppl):I98-105
17846333
J Neurochem. 2006 Sep;98(6):1886-98
16831194
J Trauma. 2008 Aug;65(2):285-97; discussion 297-9
18695463
Stroke. 1999 Sep;30(9):1851-4
10471435
Lancet. 2007 Aug 18;370(9587):575-9
17707752
Ann Neurol. 2003 Nov;54(5):582-90
14595647
J Neurosurg. 2000 Mar;92(3):435-41
10701530
Am J Physiol Cell Physiol. 2000 Jan;278(1):C144-53
10644522
Neuroreport. 2001 Feb 12;12(2):269-73
11209933
Neurosci Lett. 1999 Sep 17;272(3):207-10
10505617
J Pharmacol Exp Ther. 2001 May;297(2):474-8
11303032
J Biol Chem. 2007 Sep 21;282(38):28274-84
17664275
Stroke. 2002 Jul;33(7):1889-98
12105371
J Neurosci. 2002 Aug 1;22(15):6401-7
12151519
Proc Natl Acad Sci U S A. 1995 May 9;92(10):4666-70
7753861
CNS Neurol Disord Drug Targets. 2008 Oct;7(4):382-90
18991667
J Clin Invest. 2000 Sep;106(6):723-31
10995780
Brain Res. 2001 Aug 10;910(1-2):94-8
11489258
Am J Physiol. 1964 Aug;207:452-6
14205366